CSL Seqirus Signed an Agreement with the European Commission to Provide Pre-Pandemic Vaccines to the EU
On Jun. 11, 2024, CSL Seqirus was selected by the Health Emergency Preparedness and Response Authority (HERA), part…
Biotechnology | Infectious Disease | Life Science News | Non-Profit Research | Therapeutics | Vaccine
$140 million for UBC-led research hub to accelerate drug development and biomanufacturing
On May 31, 2024, a national research coalition led by the University of British Columbia (UBC) announced a…
Moderna received U.S. FDA approval for RSV vaccine mRESVIA
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA (mRNA-1345),…
WHO reported a substantial increase in dengue cases globally
On May 30, 2024, the World Health Organization (WHO) reported that as of 30 April 2024, over 7.6…
Biotechnology | Diagnostics | Infectious Disease | Life Science News | Medicine | Neurology | Non-Profit Research | Oncology | Therapeutics
CIRM awarded $53 million to clinical research in heart failure and cystic fibrosis, supporting 10 translational projects
On May 30, 2024, the California Institute for Regenerative Medicine (CIRM) announced it had awarded $53 million to…
BioNTech and CEPI Expanded Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
On May 29, 2024, BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) announced they were expanding their…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
CDC warned of Salmonella outbreaks linked to backyard poultry flocks
On May 23, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that 109 people from…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science History | Life Science News | Vaccine
Repeat COVID-19 vaccinations elicit antibodies that neutralize variants, other viruses
On May 17, 2024, researchers at Washington University School of Medicine in St. Louis announced a study had…
A third of U.S. food outbreaks and 3,500 illnesses tied to non-irradiated eligible food
On May, 13, 2024, the U.S. Centers for Disease Control and Prevention (CDC) reported that of 482 U.S….
National Academies reported COVID-19 vaccines don’t cause many potential harms
On May 10, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
Novavax and Sanofi announced licensing agreement to co-commercialize COVID-19 vaccine and novel COVID-19-influenza combination vaccines
On May 10, 2024, Novavax announced that it had entered into a co-exclusive licensing agreement with Sanofi. The…
Moderna announced contract with Brazil to supply 12.5 million COVID-19 vaccines as part of national vaccination campaign
On Apr. 22, 2024, Moderna announced a contract with the Ministry of Health in Brazil (Ministerio da Saude)…
Vaccine breakthrough means no more chasing strains
On Apr. 15, 2024, scientists at University of California Riverside demonstrated a new, RNA-based vaccine strategy that is…
Study suggested staying current with COVID-19 vaccinations helped combat emerging variants
On Apr. 12, 2024, Oregon Health Sciences University (OHSU) announced research that shows using live SARS-CoV-2 virus revealed…
Biotechnology | CDC | Diagnostics | Infectious Disease | Influenza | Life Science News | Therapeutics | Vaccine
CDC reported human infection with highly pathogenic avian influenza A(H5N1) virus in Texas
On Apr. 5, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that Texas had reported…
USDA confirmed highly pathogenic avian influenza USDA in dairy herd in Idaho
On Apr. 2, 2024, the U.S. Department of Agriculture (USDA) confirmed the detection of highly pathogenic avian influenza…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA | Vaccine
USDA confirmed highly pathogenic avian influenza USDA in dairy herd in New Mexico
On Apr. 1, 2024, the U.S. Department of Agriculture (USDA) confirmed the detection of highly pathogenic avian influenza…
Agriculture | Biotechnology | Diagnostics | Infectious Disease | Influenza | Life Science News | USDA
Idaho Department of Agriculture reported avian influenza detected in Cassia County dairy herd
On Mar. 28, 2024, the Idaho State Department of Agriculture (ISDA) announced it had identified a highly pathogenic…
FDA issued EUA for Pemgarda (pemivibart) for pre-exposure prophylaxis of COVID-19 in certain adults and adolescents
On Mar. 22, 2024, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for Pemgarda…
COVID reduced global life expectancy by 1.6 years
On Mar. 14, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
Novavax’s protein-based non-mRNA COVID-19 vaccine available as additional dose for individuals aged 65 and older
On Feb. 28, 2024, the U.S. Centers for Disease Control and Preventionï¾’s (CDC) Advisory Committee on Immunization Practices…
Biotechnology | Infectious Disease | Life Science News | Medicine | Non-Profit Research | Therapeutics
Alaska Department of Health confirmed first fatal case of Alaskapox virus
On Feb. 9, 2024, the state of Alaska Department of Health Alaska Department of Health confirmed the first…
Switching arms improved effectiveness of two-dose vaccinations, Oregon Health & Science University study suggested
On Feb. 6, 2024, Oregon Health & Science University (OHSU) announced research that revealed as much as a…
New COVID-19 sa-mRNA Results from CSL and Arcturus Therapeutics Demonstrated Longer Duration of Immunity Compared to Conventional COVID-19 mRNA Vaccine Booster
On Feb. 5, 2024, CSL and and Arcturus Therapeutics announced the results of a follow-up analysis of a…
First polar bear died of avian flu
On Jan. 9, 2024, biologists in Alaska have confirmed the first case of a polar bear dying after…
CCSL and Arcturus Therapeutics’ ARCT-154 Demonstrated Non-Inferiority to Original Strain and Superior Immunogenicity to Omicron BA.4/5 Variant Compared to First-Generation mRNA Vaccine Booster
On Dec. 21, 2023, CSL and and Arcturus Therapeutics announced the results of a Phase 3 study showing…
R21/Matrix-M malaria vaccine granted prequalification by World Health Organization
On Dec. 21, 2023, the World Health Organization (WHO) announced that it had prequalified the R21/Matrix-M malaria vaccine…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in Taiwan
On Dec. 18, 2023, Novavax announced that the Taiwan Food and Drug Administration had granted emergency use authorization…
NIAID scientists found Infectious SARS-CoV-2 in patient blood
On Dec. 13, 2023, National Institute of Allergy and Infectious Diseases (NIAID) scientists announced findings published in the…
Novavax’s updated COVID-19 vaccine received Emergency Use Authorization in the Republic of Korea
On Dec. 5, 2023, Novavax announced that Health Canada had granted expanded authorization for Nuvaxovid XBB.1.5 Vaccine (Recombinant…